Unexpectedly High Incidence of Interstitial Pneumonia in Newly Diagnosed Diffuse Large B-Cell Lymphoma Treated with Rituximab-CHOP-14 Supported with Pegfilgrastim.
Ercole Brusamolino(University of Pavia), Mario Lazzarino, G. Pagnucco, L Montalbetti, G. Ucci(Alessandro Manzoni Hospital), L Banfi, Enrica Morra(University of Bologna), Livio Gargantini, Giuseppe Attardo Parrinello(Radiolabs), Francesco Rodeghiero(Ospedale San Bortolo), Chiara Rusconi(Fondazione IRCCS Istituto Nazionale dei Tumori), Sergio Fava, Alberto De Paoli(University of Milan), Graziella Pinotti(Medica (Italy)), Guido Frigerio, Lilj Uziel, Luigi Rigacci(Azienda Ospedaliero-Universitaria Careggi), M. Fiumanò
Cited by 0
Related Papers
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
|New England Journal of Medicine|2014|751
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
|New England Journal of Medicine|2018|684
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
|The Lancet|2009|665
ALK+ lymphoma: clinico-pathological findings and outcome.
|PubMed|1999|569